ClinicalTrials.gov
public full text
Public Domain
A Compassionate Use Protocol of AMX0035 for Treatment of Patients With Amyotrophic Lateral Sclerosis (ALS)
The protocol is intended to provide extended treatment with AMX0035 to patients who previously participated in an Amylyx sponsored study of AMX0035 for ALS.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)#885792
- A Double-blind Randomised, Placebo-controlled Clinical Trial to Test Ambroxol Treatment in ALS#861035
- Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study#1127580
- Mesenchymal Stem Cell Injection in Amyotrophic Lateral Sclerosis#837617
- Minimum important slowing of disease progression as determined by the ALS functional rating scale – a survey of patient expectations toward disease-modifying drugs in ALS#215650
Record · ID 874928
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive